Health in Burundi 1,120 indicators covering health for Burundi. IndicatorLatest Year10-yr change Rank Probability of dying among youth ages 20-24 years, female 4.9 per 1,000 2024 down 18.3% 47th Probability of dying among adolescents ages 15-19 years, male 9.3 per 1,000 2024 down 11.4% 30th Probability of dying among adolescents ages 15-19 years, female 5.5 per 1,000 2024 down 26.7% 26th Probability of dying among adolescents ages 10-19 years, male 17.5 per 1,000 2024 down 12.5% 15th Probability of dying among adolescents ages 10-19 years, female 13 per 1,000 2024 down 20.2% 22nd Probability of dying among adolescents ages 10-14 years, male 8.3 per 1,000 2024 down 13.5% 10th Probability of dying among adolescents ages 10-14 years, female 7.6 per 1,000 2024 down 14.6% 11th Probability of dying among children ages 5-9 years, male 10.1 per 1,000 2024 down 21.7% 15th Probability of dying among children ages 5-9 years, female 9.3 per 1,000 2024 down 23.1% 15th Probability of dying among adolescents ages 10-19 years 15.3 per 1,000 2024 down 15.5% 21st Women's share of population ages 15+ living with HIV 63.3% 2024 up 4.3% 29th Maternal mortality 494.43 2020 down 18.7% 14th Prevalence of HIV, male 0.2% 2024 down 60.0% 50th Prevalence of HIV, female 0.3% 2024 down 62.5% 39th Incidence of HIV, ages 15-49 0.14 per 1,000 uninfected population ages 15-49 2024 down 69.6% 84th Incidence of HIV, all 0.1 per 1,000 uninfected population 2024 down 64.3% 77th Prevalence of overweight 16.3% 2022 up 29.4% 194th Prevalence of overweight, male 21.3% 2022 up 33.1% 172nd Prevalence of overweight, female 11.8% 2022 up 23.3% 196th Immunization, HepB3 89.0% 2024 down 6.3% 102nd Hivaids deaths and averted due to art 4,624 2024 up 21.1% 39th Future life expectancy projections 73.58 2100 up 1.6% 220th Life expectancy at age 15 75.44 2100 up 1.4% 220th Incidence of HIV, ages 50+ 0.1 per 1,000 uninfected population ages 50+ 2024 down 23.1% 38th Adults (ages 15+) and children (0-14 years) living with HIV 79,000 2024 down 12.2% 53rd Incidence of HIV, ages 15-24 0.14 per 1,000 uninfected population ages 15-24 2024 down 68.2% 71st Newborns protected against tetanus 85.0% 2024 unchanged 67th Measles - number of reported cases 795 2025 up 8,733.3% 46th Diphtheria - number of reported cases 0 2011 β 60th Total tetanus - number of reported cases 59 2025 up 1,866.7% 27th Pertussis - number of reported cases 0 2012 down 100.0% 137th Population ages 80 and above, male 15,874 2025 up 51.7% 128th Population ages 80 and above, female 26,301 2025 up 49.9% 131st Population ages 75-79, male 24,246 2025 up 40.6% 123rd Population ages 75-79, female 34,405 2025 up 37.4% 127th Population ages 70-74, male 50,213 2025 up 66.9% 121st Population ages 70-74, female 62,983 2025 up 52.7% 122nd Population ages 65-69, male 69,937 2025 up 53.4% 124th Population ages 65-69, female 82,714 2025 up 41.7% 124th Population ages 60-64, male 90,260 2025 up 18.3% 124th Population ages 60-64, female 101,598 2025 up 14.9% 123rd Population ages 55-59, male 124,506 2025 up 33.8% 118th Population ages 55-59, female 135,052 2025 up 30.7% 119th Population ages 50-54, male 175,485 2025 up 57.9% 110th Population ages 50-54, female 185,492 2025 up 55.9% 107th Population ages 45-49, male 257,374 2025 up 75.7% 99th Population ages 45-49, female 269,589 2025 up 76.3% 98th Population ages 40-44, male 360,045 2025 up 79.6% 86th Population ages 40-44, female 374,447 2025 up 81.6% 80th Population ages 35-39, male 411,370 2025 up 42.7% 84th Population ages 35-39, female 423,148 2025 up 42.8% 81st Population ages 30-34, male 429,240 2025 up 7.6% 85th Population ages 30-34, female 436,753 2025 up 6.8% 84th Population ages 25-29, male 479,428 2025 up 5.1% 81st Population ages 25-29, female 484,141 2025 up 4.5% 81st Population ages 20-24, male 626,835 2025 up 31.6% 76th Population ages 20-24, female 629,600 2025 up 31.4% 75th Population ages 15-19, male 850,731 2025 up 63.5% 68th Population ages 15-19, female 849,335 2025 up 63.4% 65th Population ages 10-14, male 1.02 million 2025 up 55.6% 63rd β Previous Page 3 of 19 Next β